CNBS 📈 Amplify Seymour Cannabis - Overview
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US0321088546 • Miscellaneous Sector
CNBS: Cannabis, Hemp, Securities, Derivatives, Ecosystem
The fund will invest at least 80% of its net assets in the securities of companies that derive 50% or more of their revenue from the cannabis and hemp ecosystem and in derivatives that have economic characteristics similar to such securities. It is an actively managed ETF that seeks to provide investment exposure to global companies principally engaged in the emerging cannabis and hemp ecosystem across one of three classifications. The fund is non-diversified.
Additional Sources for CNBS ETF
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
CNBS ETF Overview
| Market Cap in USD | 18m |
| Category | Miscellaneous Sector |
| TER | 0.75% |
| IPO / Inception | 2019-07-15 |
CNBS ETF Ratings
| Growth 5y | -89.6% |
| Fundamental | - |
| Dividend | 67.4% |
| Rel. Strength Industry | -285 |
| Analysts | - |
| Fair Price Momentum | 1.36 USD |
| Fair Price DCF | - |
CNBS Dividends
| Dividend Yield 12m | 49.89% |
| Yield on Cost 5y | 9.14% |
| Annual Growth 5y | 54.63% |
| Payout Consistency | 42.9% |
CNBS Growth Ratios
| Growth Correlation 3m | -91.2% |
| Growth Correlation 12m | -83.8% |
| Growth Correlation 5y | -80.4% |
| CAGR 5y | -28.77% |
| CAGR/Mean DD 5y | -0.46 |
| Sharpe Ratio 12m | -0.81 |
| Alpha | -75.97 |
| Beta | 1.26 |
| Volatility | 52.40% |
| Current Volume | 35.9k |
| Average Volume 20d | 124.8k |
What is the price of CNBS stocks?
As of January 15, 2025, the stock is trading at USD 1.79 with a total of 35,900 shares traded.
Over the past week, the price has changed by -12.21%, over one month by -5.42%, over three months by -37.35% and over the past year by -44.33%.
As of January 15, 2025, the stock is trading at USD 1.79 with a total of 35,900 shares traded.
Over the past week, the price has changed by -12.21%, over one month by -5.42%, over three months by -37.35% and over the past year by -44.33%.
Is Amplify Seymour Cannabis a good stock to buy?
No, based on ValueRay Analyses, Amplify Seymour Cannabis (NYSE ARCA:CNBS) is currently (January 2025) a stock to sell. It has a ValueRay Growth Rating of -89.56 and therefor a clear technical negative rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CNBS as of January 2025 is 1.36. This means that CNBS is currently overvalued and has a potential downside of -24.02%.
No, based on ValueRay Analyses, Amplify Seymour Cannabis (NYSE ARCA:CNBS) is currently (January 2025) a stock to sell. It has a ValueRay Growth Rating of -89.56 and therefor a clear technical negative rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CNBS as of January 2025 is 1.36. This means that CNBS is currently overvalued and has a potential downside of -24.02%.
Is CNBS a buy, sell or hold?
Amplify Seymour Cannabis has no consensus analysts rating.
Amplify Seymour Cannabis has no consensus analysts rating.
What are the forecast for CNBS stock price target?
According to ValueRays Forecast Model, CNBS Amplify Seymour Cannabis will be worth about 1.5 in January 2026. The stock is currently trading at 1.79. This means that the stock has a potential downside of -14.53%.
According to ValueRays Forecast Model, CNBS Amplify Seymour Cannabis will be worth about 1.5 in January 2026. The stock is currently trading at 1.79. This means that the stock has a potential downside of -14.53%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 1.5 | -14.5% |